On the contrary, if ATF3 expression in breast cancer cells was silenced by the siATF3 transfection or was suppressed by the signalling pathway inhibitor LY204002, breast cancer radioresistance could be relieved to a great extent and the radiation therapy efficiency can be also improved. This evidence concerns the gene ATF3 and breast cancer.